3yo PHfully immunized male pw daily fevers for 1012 days with intermittent bl anterior thigh pain Saw PMD day prior to admission who ordered labs and then called family today with results saying all cell counts were abnormal and told parents to bring child to CHOC ID: 912654
Download Presentation The PPT/PDF document "Leukemia: Diagnosis Patient case" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Leukemia: Diagnosis
Slide2Patient case:
3yo, PH/fully immunized male p/w daily fevers for 10-12 days, with intermittent
b/l
anterior thigh
pain
Saw PMD day prior to admission who ordered labs and then called family today with results saying “all cell counts were abnormal” and told parents to bring child to CHOC
ED
Slide3Where do you start?
HISTORY!
Keep a rough differential in mind from the chief complaint in order to tailor your questions
Ask a thorough infectious history
Possible
DDx
:
Viral
infections (
esp
EBV, CMV), TB, PNA, strep throat, UTI, otitis media, osteomyelitis, Kawasaki disease/vasculitis, leukemia, lymphoma, etc.
Slide4What questions should you ask if concerned about oncologic process?
Fever/chills/ night sweats/weight loss/ fatigue (
B-symptoms
)
SOB, cough (
possible mediastinal mass
)
Frequent infections (
immunocompromised
)
Bruising/rashes/bleeding (
low platelets
)
Bone pain (
issues with bone marrow
)
Slide5History:
Fever/chills for the past 10-12 days (forehead sensor measuring 104-105 F daily), then stopped measuring because they knew when he was having fevers
B/l
proximal leg pain started 2 weeks ago, no injury/trauma, was not bearing weight initially but has been improving recently
Night sweats ~5 times in the last 2 weeks
Abdominal pain when picking
pt
up from under his arms/sides of abdomen
No weight loss, but decreased appetite
No URI symptoms, no recent travel, no TB risk factors, no new animal exposures, no rash, no sick contacts
He is normally very active, but taking more naps
Has bruising on his shins but he is active and always bumps into stuff, bruising is normal for him on his legs
Ancillary hx:
Unremarkable
, he is UTD on vaccines
Slide6Next?
Physical Exam!
Gen:
Tired-appearing
, fussy, but not-toxic appearing
HEENT:
No
abnormal findings-no tonsillar hypertrophy/exudates, no pallor
CV: RRR, no murmurs, pulses equal
b/l
Resp: CTAB, no increased WOB
GI: NT, ND, soft,
some fullness on the right upper quadrant
, otherwise no masses
GU:
Circumcised
, testes descended,
right testicle seems slightly larger than left
but
is not firm
Extrem
: WWP, no swelling
Lymph:
N
o
cervical/clavicular/axillary/inguinal lymphadenopathy
Neuro:
Normal
tone, moving all extremities, no gross focal deficits, CNs intact
Skin:
No
rashes anywhere,
bruises noted on shins
b/l
What labs are important to get when thinking of oncologic processes?
CBC w/ diff, CMP
Remember other Tumor Lysis Labs! (LDH, uric acid, phosphorous level are
not
part of CMP!)
Blood culture!
DIC panel (don’t forget this!)
Consider
CRP/
ESR
Infectious work-up as indicated (UA, urine culture,
resp
panel, viral titers,
Quantiferon
, etc.)
Slide8Results:
Slide9What is your differential now?
Hopefully an oncologic process by now!
ALL (most common childhood cancer) & AML
AML and ALL are caused by sporadic mutations, it is not
hereditary
This is important when counseling the parents
There is nothing that parents could have done to have prevented it
Other siblings and future children are not at higher risk and do not need to “get tested”
Slide10What do you need to consider at this point?
Very elevated WBC
(191.8)
Need to immediately consider:
1. Has great potential for Tumor Lysis Syndrome
2.
Vaso
-occlusive crisis
Get Chest XR:
T cell ALL can have mediastinal mass
Lymphoma can have a mediastinal mass
Slide11Tumor Lysis:
Is he in Tumor
Lysis
now?
Electrolytes seem stable, but he is at a very high risk
Be careful! Even giving fluids can cause cells to lyse!
Monitor labs frequently!
Slide12Tumor Lysis:
The organs we typically worry about during Tumor Lysis:
1. Kidneys:
Uric
acid deposits in the kidney and cause injury
2. Liver:
Uric
acid deposits and can cause liver injury
3. Heart:
Elevated
K+ can cause arrhythmia/V fib or V tach
Treatment:
Hyperkalemia
: Stabilize
cardiac membrane if evidence of heart involvement with
C
alcium Gluconate, Lasix and Kayexalate, Insulin, AlbuterolElevated uric acid: Allopurinol or rasburicase
Hyperphosphatemia: AlternaGel (binds to phosphorous)Allopurinol is usually started as TID medication, rasburicase is usually once daily, AlternaGel is usually started as q 4 hrs.Sometimes these kids need to be monitored very closely in the PICU with frequent lab draws
Slide13Slide14Vaso-occlusive
issues:
Immature blasts are “sticky” can cause similar issues seen in patients with Sickle Cell disease
Priapism, stroke, kidney injury, etc.
Need to monitor
patient very closely
With this patient, be careful with RBC transfusion because it can
worsen
or induce
vaso
-occlusive issues
May be worth holding off on transfusion if
pt
is not symptomatic and if you do, can
give
pRBCs
aliquots and infuse very slowly
Slide15If you have a chance, go to the pathologist (in the basement of CHOC), and you can see the peripheral smear. This is similar to what we saw:
Slide16Slide17Diagnosis:
Bone marrow is Gold Standard
To diagnose leukemia, you need >20
%
blasts in the bone marrow
Can also send
peripheral
blood for Flow Cytometry
Lower CD numbers (CD4, CD8) are typically T cells
Higher CD numbers (CD19, CD20) are typically B cells
Slide18High risk leukemia:
Criteria that makes you high risk:
1. Initial WBC at presentation: >50 K
2. Age: <1 year or >10years
3. Testicular involvement (usually unilateral, large, and firm)
4. CNS involvement
Also high risk
if:
Unfavorable genetics (such as Philadelphia chromosome)
N
ot
under
remission
at the end of Induction (Day 29)
Slide19Treatment:
Many clinical trials out there and depending on the cancer, treatment regimen differs
For ALL however,
induction
(first month of treatment) is mostly the same:
Day 1:
Lumbar puncture
(to look for CNS involvement)
Intrathecal cytarabine: Day 1
Vincristine: Day 1, 8,15, 22
Dexamethasone: Days 1-28
Pegasparagase
: Day 4
Intrathecal Methotrexate: Day 8 and 29
Slide20Day 29:
Bone marrow biopsy is done again on Day 29 and we look for
Minimal Residual Disease (MRD)
:
The hope is that the blast cells are <0.01 % (down from >20% on initial
bone
marrow biopsy)
If >0.01%, they are classified under high risk and will need more intense chemotherapy going forward
Slide21Our kid:
Flow cytometry showed:
AML
(usually get ~10 new diagnoses of AML a year at CHOC). Most new diagnoses are ALL (again the most common childhood cancer). This was also confirmed on
bone
marrow
biopsy
Started on a new clinical trial (St.
Judes
AML
Study), consisting
of intrathecal
(Methotrexate
+
Hydrocortisone
+
Cytarabine), Azacitadine, Cytarabine, Dauorubicin, and EtoposideHe had no CNS involvement or testicular involvement, but because of his WBC >50 K, he is considered high riskInitially, we gave 6cc/kg
pRBC transfusion, CXR showed no mass, gave platelet transfusion as he needed procedures to get a central line in, LP, and bone marrowWhen starting chemo, we monitored WBC with daily CBC, tumor lysis labs every 6 hrs, gave Rasburicase, Allopurinol TID, and Alternagel every 4
hoursHe is currently Day 7 of treatment and doing well and stable. WBC is still 151
Slide22Important to remember:
US has one of the better survival rates for childhood cancers than other countries. Not because we have better chemotherapy regimens, it is because of the supportive
care
Nutrition (optimizing diet and even TPN if needed),
Psychology
, empiric Abx if needed, family and patient support/well-being
,
access to the hospital, controlling nausea and constipation, acting fast on side-effects when they
arise,
all play a huge role in the survivorship of our
Onc
patients